These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


294 related items for PubMed ID: 8240318

  • 1. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
    Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, Weinstein IB.
    Biochem Biophys Res Commun; 1993 Oct 29; 196(2):1010-6. PubMed ID: 8240318
    [Abstract] [Full Text] [Related]

  • 2. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma.
    Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M.
    Cancer Res; 1994 Jun 15; 54(12):3107-10. PubMed ID: 8205525
    [Abstract] [Full Text] [Related]

  • 3. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
    Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G.
    Cancer Res; 1994 Apr 01; 54(7):1812-7. PubMed ID: 8137296
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB.
    Oncogene; 1993 Dec 01; 8(12):3447-57. PubMed ID: 8247550
    [Abstract] [Full Text] [Related]

  • 5. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P, Fernández PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A.
    Cancer Res; 1994 Sep 01; 54(17):4813-7. PubMed ID: 8062283
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms in cyclin D1 gene and hepatocellular carcinoma.
    Zhang YJ, Chen SY, Chen CJ, Santella RM.
    Mol Carcinog; 2002 Feb 01; 33(2):125-9. PubMed ID: 11813305
    [Abstract] [Full Text] [Related]

  • 7. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, Ruggeri BA.
    Mol Carcinog; 1996 Feb 01; 15(2):85-95. PubMed ID: 8599583
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK, Bang YJ.
    Biochem Biophys Res Commun; 2002 Mar 29; 292(2):383-9. PubMed ID: 11906173
    [Abstract] [Full Text] [Related]

  • 9. Amplification and expression of the human cyclin D gene in esophageal cancer.
    Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein IB.
    Cancer Res; 1992 May 15; 52(10):2980-3. PubMed ID: 1533816
    [Abstract] [Full Text] [Related]

  • 10. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP.
    Cancer; 1997 Jan 15; 79(2):380-9. PubMed ID: 9010112
    [Abstract] [Full Text] [Related]

  • 11. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
    Bringuier PP, Tamimi Y, Schuuring E, Schalken J.
    Oncogene; 1996 Apr 18; 12(8):1747-53. PubMed ID: 8622895
    [Abstract] [Full Text] [Related]

  • 12. Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas.
    Tsuruta H, Sakamoto H, Onda M, Terada M.
    Biochem Biophys Res Commun; 1993 Nov 15; 196(3):1529-36. PubMed ID: 8250909
    [Abstract] [Full Text] [Related]

  • 13. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer.
    Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T.
    Am J Pathol; 1995 May 15; 146(5):1161-9. PubMed ID: 7747810
    [Abstract] [Full Text] [Related]

  • 14. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A.
    Mod Pathol; 1995 Jun 15; 8(5):560-7. PubMed ID: 7675778
    [Abstract] [Full Text] [Related]

  • 15. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
    Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P, Rosen N.
    Oncogene; 1994 Jul 15; 9(7):1925-9. PubMed ID: 8208539
    [Abstract] [Full Text] [Related]

  • 16. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ.
    Oncogene; 1992 Feb 15; 7(2):355-61. PubMed ID: 1532244
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M.
    Hepatology; 1999 Jul 15; 30(1):90-9. PubMed ID: 10385644
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.
    Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, Nanney LB, Shyr Y, Beauchamp RD.
    Cancer Res; 2001 Jul 15; 61(14):5389-95. PubMed ID: 11454681
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.